Unknown

Dataset Information

0

Identification and Characterization of Extrachromosomal Circular DNA in Human Placentas With Fetal Growth Restriction.


ABSTRACT: Many studies have confirmed that extrachromosomal circular DNAs (eccDNAs/ecDNAs) exist in tumor and normal cells independently of the chromosome and are essential for oncogene plasticity and drug resistance. Studies have confirmed that there are many eccDNAs/ecDNAs in maternal plasma derived from the fetus. Fetal growth restriction (FGR) is a pregnancy-related disease associated with high newborn morbidity and mortality. However, the characteristics and nature of eccDNAs/ecDNAs in FGR are poorly understood. This study aims to deconstruct the properties and potential functions of eccDNAs/ecDNAs in FGR. We performed circle-seq to identify the expression profile of eccDNAs/ecDNAs, analyzed by bioinformatics, and verified by real-time Polymerase Chain Reaction (PCR) combined with southern blot in FGR compared with the normal groups. A total of 45,131 eccDNAs/ecDNAs (including 2,118 unique ones) were identified, which had significantly higher abundance in FRG group than in normal group, and was bimodal in length, peaking at ~146bp and ~340bp, respectively. Gestational age may be one independent factor affecting the production of eccDNAs/ecDNAs, most of which come from genomic regions with high gene density, with a 4~12bp repeat around the junction, and their origin had a certain genetic preference. In addition, some of the host-genes overlapped with non-coding RNAs (ncRNAs) partially or even completely. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that host-genes on the differentially expressed eccDNAs/ecDNAs (DEEECs/DEECs) were mainly enriched in immune-related functions and pathways. The presence of some ecDNAs were verified, and whose variability were consistent with the circle-seq results. We identified and characterized eccDNAs/ecDNAs in placentas with FGR, and elucidated the formation mechanisms and the networks with ncRNAs, which provide a new vision for the screening of new biomarkers and therapeutic targets for FGR.

SUBMITTER: Yang H 

PROVIDER: S-EPMC8724250 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6983429 | biostudies-literature
| S-EPMC10354665 | biostudies-literature
| S-EPMC9113459 | biostudies-literature
| S-EPMC3154432 | biostudies-literature
| S-EPMC10144670 | biostudies-literature
| S-EPMC9935582 | biostudies-literature
| S-EPMC7899950 | biostudies-literature
| S-EPMC4475933 | biostudies-literature
| S-EPMC10948907 | biostudies-literature
| S-EPMC3199758 | biostudies-literature